CIPRO

LOE Approaching

ciprofloxacin

NDAORALFOR SUSPENSION
Approved
Sep 1997
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Clinical Trials
43

Mechanism of Action

[see Microbiology ()].

Clinical Trials (5)

NCT07200830Phase 3Not Yet Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Started Oct 2025
1,524 enrolled
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
NCT06815536N/ARecruiting

Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

Started Apr 2025
3,291 enrolled
Neisseria Gonorrheae Infection
NCT07029126N/ARecruiting

Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

Started Oct 2024
300 enrolled
Migraine
NCT04678869N/AActive Not Recruiting

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)

Started Jun 2022
313 enrolled
Acute Lymphoblastic Leukaemia - Category
NCT04636957Phase 3Unknown

A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)

Started Nov 2020
600 enrolled
Acute Otitis Externa